Use of placebos and post-trial benefits

Autores

  • Ricardo Perlingeiro
  • Carmen Silvia Arruda

Resumo

Brazilian legislators have not yet enacted any laws regarding the use of placebos and the duties of assistance to research subjects. As a result of this omission, public administrative authorities have to deal with the subject on a regular basis, oriented by fundamental rights and judicial supervision. Against that backdrop, CNS (National Health Council)2, speaking through CONEP (National Research Ethics Committee)3, ANVISA (Healthcare Surveillance Agency)4, the CFM (Federal Medical Council)5, the CNJ (National Justice Council)6 and the STF (Federal Supreme Court)7 have expressed their opinions on the subject in a consistent manner. [...]

Downloads

Não há dados estatísticos.

Biografia do Autor

Ricardo Perlingeiro

Professor of Law at Universidade Federal Fluminense (UFF) – Niterói (RJ), Brazil; Federal Judge in Rio de Janeiro.

Carmen Silvia Arruda

Master degree candidate in Administrative Justice at Universidade Federal Fluminense (UFF) – Niterói (RJ), Brazil; Federal Judge in Rio de Janeiro.

Publicado

2022-03-28

Como Citar

1.
Perlingeiro R, Arruda CS. Use of placebos and post-trial benefits. DST [Internet]. 28º de março de 2022 [citado 21º de novembro de 2024];25(4):169-70. Disponível em: https://bdst.emnuvens.com.br/revista/article/view/763

Edição

Seção

Editorial